LatestNews

ExonHit and BioMérieux end colon cancer collaboration – 10-Mar-2010

The partners say the clinical data did not reach the required level of performance.

Patent applications published 24 February 2010 – 10-Mar-2010

Patent applications taken from the weekly European Patents Bulletin

Patent applications published 17 February 2010 – 10-Mar-2010

Patent applications taken from the weekly European Patents Bulletin

Patent applications published 10 February 2010 – 10-Mar-2010

Patent applications taken from the weekly European Patents Bulletin

Patent applications published 3 February 2010 – 10-Mar-2010

Patent applications are taken from the weekly European Patents Bulletin

Ricerca completes purchase of MDS Pharma businesses – 10-Mar-2010

The acquisition gives Ohio-based Ricerca more capacity and capabilities.

Sicor Biotech orders biotech facility from Pharmadule – 10-Mar-2010

Pharmadule has signed a contract with Sicor Biotech for the delivery of a biotech facility.

Cellzome signs second inflammatory disease alliance with GSK – 10-Mar-2010

The collaboration will exploit Cellzome's proteomics technology in epigenetics.

Diabetes market to see rapid growth, says Datamonitor – 10-Mar-2010

But one of the main growth drivers of type 2 diabetes drugs will not be addressed on a large scale.

Abbott to acquire Facet Biotech – 10-Mar-2010

The deal provides a promising biologic to treat multiple sclerosis.

BT Pharma becomes Genticel and secures €13m in funding – 9-Mar-2010

Genticel will focus its efforts on the prevention of cervical cancer in HPV infected women.

Nano particles carry drugs to diseased cells – 9-Mar-2010

Researchers grow empty particles derived from a plant virus and make them carry useful chemicals.

Lonza and Odyssey Thera create ‘winning combination’ – 9-Mar-2010

Lonza collaborates with and takes a minority stake in Odyssey Thera.

Pfizer and King’s College collaborate on pain research – 9-Mar-2010

Pfizer and King’s College London have created an open innovation laboratory for pain research.

MicroConstants offers nanoparticle formulation service – 8-Mar-2010

MicroConstants' nanosizing technology transforms water insoluble compounds into nanoparticles.